Insider Transactions Reported by 21 Insiders of Xenon Pharmaceuticals Inc.

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	0
Sells	2	-90,305	100%	$43.50	-$3,928,064
Net	-2	-90,305	-100%		-$3,928,064

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Michael R. Hayden	Director	$3,178,448			03 Jun 2021
FRANK A. HOLLER	Director	$1,426,644			27 May 2021
GARY PATOU	Director	$1,168,899			05 Jun 2025
IAN MORTIMER	PRESIDENT & CEO, Director	$893,918	-$3,927,972	-81%	09 Jan 2026
MICHAEL M. TARNOW	Director	$767,729			18 May 2021
MOHAMMAD AZAB	Director	$731,116			19 Dec 2023
SHERRINGTON ROBIN	EVP, Strategy & Innovation	$388,827			11 Mar 2024
STEVEN GANNON	Director	$217,657	-$91	-0.04%	05 Jun 2025
SIMON N. PIMSTONE	Director	$59,100			02 Jun 2023
SHERRY AULIN	Chief Financial Officer	$0			18 Dec 2024
Dawn Svoronos	Director				05 Jun 2025
JAMES R. EMPFIELD	EVP, Drug Discovery				11 Mar 2024
CHRISTOPHER JOHN KENNEY	Chief Medical Officer				09 Jan 2026
Andrea DiFabio	Chief Legal Officer				09 Jan 2026
Christopher Von Seggern	Chief Commercial Officer				11 Mar 2024
Darren S. Cline	Chief Commercial Officer				09 Jan 2026
ELIZABETH A. GAROFALO	Director				05 Jun 2025
Gillian Cannon	Director				05 Jun 2025
Thomas Patrick Kelly	Chief Financial Officer				15 Oct 2025
Patrick Machado	Director				05 Jun 2025
Justin D. Gover	Director				05 Jun 2025

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.